This process is accompanied by the decreased expression of multiple proteins, such as NUSAP1, indicating that the downregulation of NUSAP1 may suppress GC cell proliferation and enhance the anti-tumor efficacy of medicines (120). Here, NUSAP1 is linked to neoplasm.